Wednesday, September 26, 2018 8:44:49 AM
Biolog’s CEO Bruce Bauer stated: “Our license from Lexaria is what separates Biolog products from all others. By incorporating the DehydraTECH™ drug delivery platform into our products, the bitterness and the earthy taste of cannabis oil are masked, and this technology ensures quick and effective transportation into the bloodstream without degradation in the stomach or liver. This equates to decreased onset times, a 300% increase in bioavailability and more accurate dosing. The cannabidiol (CBD) market is projected to reach $2.1 billion by 2020. In my opinion our work with Lexaria Biosciences will prove to be a highly and mutually beneficial business relationship.”
Recent LOAN News
- Manhattan Bridge Capital, Inc. Declares Quarterly Dividend • GlobeNewswire Inc. • 07/29/2024 11:00:00 AM
- Manhattan Bridge Capital, Inc. Reports Second Quarter 2024 Results • GlobeNewswire Inc. • 07/22/2024 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/22/2024 11:00:38 AM
- Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/05/2024 04:15:22 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/22/2024 12:00:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/09/2024 11:00:12 AM
- Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2024 • GlobeNewswire Inc. • 04/23/2024 11:05:00 AM
- Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend • GlobeNewswire Inc. • 03/28/2024 11:00:00 AM
- Manhattan Bridge Capital, Inc. Declares Quarterly Dividend • GlobeNewswire Inc. • 03/12/2024 11:00:00 AM
- Manhattan Bridge Capital, Inc. Reports Results for 2023 • GlobeNewswire Inc. • 03/11/2024 11:05:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2024 11:00:31 AM
- Manhattan Bridge Capital, Inc. Declares an Increased Quarterly Dividend of $0.115 per Share • GlobeNewswire Inc. • 02/07/2024 12:00:00 PM
- Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend • GlobeNewswire Inc. • 12/27/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 12:00:37 PM
- Manhattan Bridge Capital, Inc. Declares Quarterly Dividend • GlobeNewswire Inc. • 11/28/2023 12:00:00 PM
- Manhattan Bridge Capital, Inc. Reports Third Quarter 2023 Results • GlobeNewswire Inc. • 10/24/2023 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/24/2023 11:00:24 AM
- Manhattan Bridge Capital, Inc. Announces Payment of Quarterly Dividend • GlobeNewswire Inc. • 09/26/2023 11:00:00 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM